The COVID-19 Long Haul Foundation

Treatment, Referral & Educational Support for COVID-19 Illnesses & Vaccine Injury

COVID-19–Associated Transverse Myelitis: Immunopathogenesis, Genomic Susceptibility, Clinical Phenotypes, Diagnostic Advances, Therapeutic Strategies, and Long-Term Outcomes

Abstract Transverse myelitis (TM) is an inflammatory disorder of the spinal cord characterized by acute or subacute development of bilateral motor, sensory, and autonomic dysfunction attributable to focal spinal cord […]

COVID-19 and the Motor–Sensory Brain: Pathobiology, Microvascular Injury, Neurophysiology, Clinical Manifestations, Therapeutic Strategies, and Long-Term Outcomes

John Murphy, CEO COVID-19 Long-haul Founndation Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), initially characterized as a respiratory pathogen, is now recognized as a systemic vascular and neurotropic disease […]

Persistent Viral Reservoirs and Immune Dysregulation in Long COVID

John Murphy, M.D., M.P.H., D.P.H., President Covid-19 Long-haul Foundation The Central Discovery Reshaping Post-Acute Sequelae Research Abstract Long COVID (post-acute sequelae of SARS-CoV-2 infection, PASC) has emerged as a multisystem […]

Severe cerebral amyloid angiopathy related inflammation (CAA-ri) associated with vaccination

Michael Tang 1, Jane Kim 2, Kui Kai Lau 3, Koon Ho Chan 3, PMID: 39094435, DOI: 10.1016/j.jneuroim.2024.578406 Abstract Cerebral amyloid angiopathy-related inflammation (CAA-ri) is a rapid but reversible autoimmune encephalopathy where spontaneous autoantibody reaction against amyloid beta deposited […]

Amyloid β-related angiitis of the central nervous system occurring after COVID-19 vaccination: A case report

Mayuri Kizawa 1, Yasushi Iwasaki, PMCID: PMC9791501  PMID: 36579089 Abstract BACKGROUND Although coronavirus disease 2019 (COVID-19) vaccines have been effective in controlling the COVID-19 pandemic, a variety of post-vaccination neurological complications have been reported worldwide. […]

Long-COVID: assessment of circulating markers suggests no cerebral neuronal damage, neuroinflammation or systemic inflammation–a controlled study

Roald Omdal, Ole Bernt Lenning, Grete Jonsson, Scientific Reports , Article number:  (2026) Cite this article We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript […]

Cerebral amyloid angiopathy – Related inflammation after COVID-19 vaccination: Case or causality?

Francesco Rossato a, Gianmarco Gazzola a, Valentina Carlucci a, et. al. PMCID: PMC8498485 Background and aims Cerebral amyloid angiopathy (CAA) is characterized by microangiopathy with increased susceptibility to hemorrhages. Some patients may develop an inflammatory form […]